• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自组装纳米颗粒中的透明质酸:靶向癌症治疗的无限可能

Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy.

作者信息

Curcio Manuela, Vittorio Orazio, Bell Jessica Lilian, Iemma Francesca, Nicoletta Fiore Pasquale, Cirillo Giuseppe

机构信息

Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende, Italy.

Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sidney, NSW 2052, Australia.

出版信息

Nanomaterials (Basel). 2022 Aug 18;12(16):2851. doi: 10.3390/nano12162851.

DOI:10.3390/nano12162851
PMID:36014715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9413373/
Abstract

Self-assembling nanoparticles (SANPs) based on hyaluronic acid (HA) represent unique tools in cancer therapy because they combine the HA targeting activity towards cancer cells with the advantageous features of the self-assembling nanosystems, i.e., chemical versatility and ease of preparation and scalability. This review describes the key outcomes arising from the combination of HA and SANPs, focusing on nanomaterials where HA and/or HA-derivatives are inserted within the self-assembling nanostructure. We elucidate the different HA derivatization strategies proposed for this scope, as well as the preparation methods used for the fabrication of the delivery device. After showing the biological results in the employed in vivo and in vitro models, we discussed the pros and cons of each nanosystem, opening a discussion on which approach represents the most promising strategy for further investigation and effective therapeutic protocol development.

摘要

基于透明质酸(HA)的自组装纳米颗粒(SANPs)是癌症治疗中的独特工具,因为它们将HA对癌细胞的靶向活性与自组装纳米系统的优势特性相结合,即化学多功能性、易于制备和可扩展性。本综述描述了HA和SANPs结合产生的关键成果,重点关注HA和/或HA衍生物插入自组装纳米结构中的纳米材料。我们阐明了为此目的提出的不同HA衍生化策略,以及用于制造递送装置的制备方法。在展示了在体内和体外模型中获得的生物学结果后,我们讨论了每个纳米系统的优缺点,开启了关于哪种方法代表最有前景的策略以进行进一步研究和有效治疗方案开发的讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/04671b494e0a/nanomaterials-12-02851-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/edb38d7d8d60/nanomaterials-12-02851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/ef47544a5aa7/nanomaterials-12-02851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/c36fcd18ca06/nanomaterials-12-02851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/dded977241e7/nanomaterials-12-02851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/2aff9ce072e1/nanomaterials-12-02851-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/61662276cdbe/nanomaterials-12-02851-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/04671b494e0a/nanomaterials-12-02851-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/edb38d7d8d60/nanomaterials-12-02851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/ef47544a5aa7/nanomaterials-12-02851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/c36fcd18ca06/nanomaterials-12-02851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/dded977241e7/nanomaterials-12-02851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/2aff9ce072e1/nanomaterials-12-02851-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/61662276cdbe/nanomaterials-12-02851-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3408/9413373/04671b494e0a/nanomaterials-12-02851-g007.jpg

相似文献

1
Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy.自组装纳米颗粒中的透明质酸:靶向癌症治疗的无限可能
Nanomaterials (Basel). 2022 Aug 18;12(16):2851. doi: 10.3390/nano12162851.
2
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.基于透明质酸的自组装纳米系统用于 CD44 靶向介导的固体肿瘤 siRNA 递药。
Biomaterials. 2013 Apr;34(13):3489-502. doi: 10.1016/j.biomaterials.2013.01.077. Epub 2013 Feb 11.
3
Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.氧化还原响应性和双靶向透明质酸-甲氨蝶呤前药自组装纳米粒子用于增强细胞内药物自递送
Mol Pharm. 2019 Jul 1;16(7):3133-3144. doi: 10.1021/acs.molpharmaceut.9b00359. Epub 2019 Jun 14.
4
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use.载唑来膦酸的杂化自组装纳米粒子:促进其临床应用的策略。
Int J Mol Sci. 2022 May 5;23(9):5138. doi: 10.3390/ijms23095138.
5
Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.用于多西紫杉醇靶向递送至乳腺癌的聚(D,L-丙交酯-co-乙交酯)/透明质酸嵌段共聚物的可生物降解自组装纳米粒子。
Biomaterials. 2014 Jan;35(1):550-66. doi: 10.1016/j.biomaterials.2013.09.089. Epub 2013 Oct 15.
6
Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.用于短发夹RNA编码质粒双靶向递送的逆-反向d-肽修饰透明质酸/生物可还原超支化聚(酰胺胺)/pDNA核壳三元纳米颗粒
Acta Biomater. 2017 Jul 15;57:156-169. doi: 10.1016/j.actbio.2017.04.024. Epub 2017 Apr 22.
7
Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.用于原位膀胱癌光热消融的自组装肿瘤靶向透明质酸纳米颗粒
Acta Biomater. 2017 Apr 15;53:427-438. doi: 10.1016/j.actbio.2017.02.021. Epub 2017 Feb 15.
8
Hyaluronan Graft Copolymers Bearing Fatty-Acid Residues as Self-Assembling Nanoparticles for Olanzapine Delivery.带有脂肪酸残基的透明质酸接枝共聚物作为用于奥氮平递送的自组装纳米颗粒
Pharmaceutics. 2019 Dec 12;11(12):675. doi: 10.3390/pharmaceutics11120675.
9
Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.简便制备稳定的、透明质酸修饰的、二硫键交联的 PLGA 纳米粒用于肿瘤靶向和还原响应性的多西紫杉醇释放
Acta Biomater. 2021 Apr 15;125:280-289. doi: 10.1016/j.actbio.2021.02.044. Epub 2021 Mar 4.
10
Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.利用自组装透明质酸纳米载体传递靶向线粒体的阿霉素衍生物治疗多柔比星耐药乳腺癌。
Acta Pharmacol Sin. 2018 Oct;39(10):1681-1692. doi: 10.1038/aps.2018.9. Epub 2018 May 31.

引用本文的文献

1
Tailoring Self-Assembled Peptide Hydrogels with Antimicrobial or Cell Adhesive Properties for Tissue Engineering.定制具有抗菌或细胞黏附特性的自组装肽水凝胶用于组织工程。
Chemistry. 2025 Jul 17;31(40):e202500975. doi: 10.1002/chem.202500975. Epub 2025 Jun 27.
2
Facile One-Pot Preparation of Self-Assembled Hyaluronate/Doxorubicin Nanoaggregates for Cancer Therapy.用于癌症治疗的透明质酸/阿霉素纳米聚集体的简便一锅法制备
Biomimetics (Basel). 2025 Feb 6;10(2):91. doi: 10.3390/biomimetics10020091.
3
MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy.

本文引用的文献

1
Recent advances in anti-multidrug resistance for nano-drug delivery system.纳米药物递送系统抗多药耐药性的最新进展。
Drug Deliv. 2022 Dec;29(1):1684-1697. doi: 10.1080/10717544.2022.2079771.
2
Recent progress in the early detection of cancer based on CD44 biomarker; nano-biosensing approaches.基于CD44生物标志物的癌症早期检测的最新进展;纳米生物传感方法。
Life Sci. 2022 Jul 1;300:120593. doi: 10.1016/j.lfs.2022.120593. Epub 2022 Apr 29.
3
Tumor Tropic Delivery of Hyaluronic Acid-Poly (D,L-lactide-co-glycolide) Polymeric Micelles Using Mesenchymal Stem Cells for Glioma Therapy.
金属有机框架衍生的智能华蟾毒精纳米复合材料具有葡萄糖代谢抑制作用,用于增强生物能量疗法以及集成光热-化学动力学-化学疗法。
J Nanobiotechnology. 2025 Jan 16;23(1):19. doi: 10.1186/s12951-024-03084-1.
4
Hyaluronic Acid Nanoparticles with Parameters Required for Applications: From Synthesis to Parametrization.具有应用所需参数的透明质酸纳米颗粒:从合成到参数化。
Biomacromolecules. 2024 Aug 12;25(8):4934-4945. doi: 10.1021/acs.biomac.4c00370. Epub 2024 Jun 29.
5
Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies.基于蜂毒素的纳米粒在抗肿瘤治疗中的最新进展:从作用机制到靶向递药策略。
J Nanobiotechnology. 2023 Nov 28;21(1):454. doi: 10.1186/s12951-023-02223-4.
6
Biosynthesized nanoparticles: a novel approach for cancer therapeutics.生物合成纳米颗粒:一种癌症治疗的新方法。
Front Med Technol. 2023 Jul 13;5:1236107. doi: 10.3389/fmedt.2023.1236107. eCollection 2023.
7
Nanomaterials for Drug Delivery and Cancer Therapy.用于药物递送与癌症治疗的纳米材料
Nanomaterials (Basel). 2023 Jan 3;13(1):207. doi: 10.3390/nano13010207.
利用间充质干细胞对脑胶质瘤进行肿瘤靶向递送透明质酸-聚(D,L-丙交酯-co-乙交酯)聚合物胶束治疗。
Molecules. 2022 Apr 8;27(8):2419. doi: 10.3390/molecules27082419.
4
Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.基于环糊精组装的多功能协同转运载体用于癌症协同治疗。
Theranostics. 2022 Feb 28;12(6):2560-2579. doi: 10.7150/thno.70243. eCollection 2022.
5
CD44/Folate Dual Targeting Receptor Reductive Response PLGA-Based Micelles for Cancer Therapy.用于癌症治疗的基于聚乳酸-羟基乙酸共聚物的CD44/叶酸双靶向受体还原响应胶束
Front Pharmacol. 2022 Mar 10;13:829590. doi: 10.3389/fphar.2022.829590. eCollection 2022.
6
Self-assembly of nanomicelles with rationally designed multifunctional building blocks for synergistic chemo-photodynamic therapy.基于合理设计的多功能构建基元的纳米胶束自组装用于协同化学-光动力疗法。
Theranostics. 2022 Jan 31;12(5):2028-2040. doi: 10.7150/thno.68563. eCollection 2022.
7
Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer.挑战癌症多药耐药性的新型纳米技术的最新进展
Front Pharmacol. 2022 Feb 14;13:776895. doi: 10.3389/fphar.2022.776895. eCollection 2022.
8
Smart Lipid-Polysaccharide Nanoparticles for Targeted Delivery of Doxorubicin to Breast Cancer Cells.用于将阿霉素靶向递送至乳腺癌细胞的智能脂质-多糖纳米颗粒
Int J Mol Sci. 2022 Feb 21;23(4):2386. doi: 10.3390/ijms23042386.
9
Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy.利用自组装纳米生物材料提高癌症免疫疗法。
Cancer Cell. 2022 Mar 14;40(3):255-276. doi: 10.1016/j.ccell.2022.01.006. Epub 2022 Feb 10.
10
Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy.纯药物纳米聚集体:一种用于高效癌症治疗的简便无载体纳米平台。
Acta Pharm Sin B. 2022 Jan;12(1):92-106. doi: 10.1016/j.apsb.2021.08.012. Epub 2021 Aug 14.